Using a polyclonal antibody we developed against a shared sequence on human and mouse CAP2 (SEKIQEIQTFRERNR; a.a. 111–125), we found that CAP2 was virtually undetectable in breast cancer cells, whereas it was highly expressed in HeLa cells (Fig. S1). Here, CAP2 is linked to breast carcinoma.